|
|
| | STS-E412 Basic information |
| Product Name: | STS-E412 | | Synonyms: | STS-E412;[1,2,4]Triazolo[1,5-a]pyrimidine, 2-[2-(4-chlorophenoxy)ethoxy]-5,7-dimethyl-;STS E412,STS-E-412;2-(2-(4-Chlorophenoxy)ethoxy)-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine | | CAS: | 1609980-39-3 | | MF: | C15H15ClN4O2 | | MW: | 318.76 | | EINECS: | | | Product Categories: | | | Mol File: | 1609980-39-3.mol |  |
| | STS-E412 Chemical Properties |
| form | Solid | | color | White to off-white |
| | STS-E412 Usage And Synthesis |
| Description | STS-E412 is the first nonpeptidyl, selective activator of the tissue-protective EPOR/CD131 receptor. | | Uses | STS-E412 is a selective activator of tissue-protective EPO receptor (including EPOR and CD131). STS-E412 can be used for research of neurodegenerative diseases and organ protection[1]. | | References | [1] Miller JL, et al. Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor. Mol Pharmacol. 2015 Aug;88(2):357-67. DOI:10.1124/mol.115.098400 |
| | STS-E412 Preparation Products And Raw materials |
|